Amylyx Pharmaceuticals, Inc. (AMLX)
13.99
-0.39
(-2.71%)
USD |
NASDAQ |
Mar 13, 16:00
13.72
-0.27
(-1.93%)
After-Hours: 20:00
Amylyx Pharmaceuticals EPS Diluted (Quarterly) : -0.3004 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Disc Medicine, Inc. | -1.618 |
| Cytokinetics, Inc. | -1.495 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| MediciNova, Inc. | -0.057 |
| Scholar Rock Holding Corp. | -0.8824 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.00M |
| Total Expenses (Quarterly) | 33.00M |
| Enterprise Value | 1.235B |
| Earnings Yield | -11.10% |
| Normalized Earnings Yield | -11.10 |